Literature DB >> 18162107

Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data.

Rui Song1, Michael R Kosorok1, Jianwen Cai1.   

Abstract

Recurrent events data are frequently encountered in clinical trials. This article develops robust covariate-adjusted log-rank statistics applied to recurrent events data with arbitrary numbers of events under independent censoring and the corresponding sample size formula. The proposed log-rank tests are robust with respect to different data-generating processes and are adjusted for predictive covariates. It reduces to the Kong and Slud (1997, Biometrika 84, 847-862) setting in the case of a single event. The sample size formula is derived based on the asymptotic normality of the covariate-adjusted log-rank statistics under certain local alternatives and a working model for baseline covariates in the recurrent event data context. When the effect size is small and the baseline covariates do not contain significant information about event times, it reduces to the same form as that of Schoenfeld (1983, Biometrics 39, 499-503) for cases of a single event or independent event times within a subject. We carry out simulations to study the control of type I error and the comparison of powers between several methods in finite samples. The proposed sample size formula is illustrated using data from an rhDNase study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162107      PMCID: PMC2795392          DOI: 10.1111/j.1541-0420.2007.00948.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  12 in total

1.  Sample size calculations for the two-sample problem using the multiplicative intensity model.

Authors:  M V Bernardo; D P Harrington
Journal:  Stat Med       Date:  2001-02-28       Impact factor: 2.373

2.  Using auxiliary time-dependent covariates to recover information in nonparametric testing with censored data.

Authors:  S Murray; A A Tsiatis
Journal:  Lifetime Data Anal       Date:  2001-06       Impact factor: 1.588

3.  Causal inference on the difference of the restricted mean lifetime between two groups.

Authors:  P Y Chen; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

4.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

5.  Sample size calculations for comparative clinical trials with over-dispersed Poisson process data.

Authors:  Shigeyuki Matsui
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

6.  Robust estimation of the variance in moment methods for extra-binomial and extra-Poisson variation.

Authors:  D F Moore; A Tsiatis
Journal:  Biometrics       Date:  1991-06       Impact factor: 2.571

7.  Power considerations for clinical trials using multivariate time-to-event data.

Authors:  M D Hughes
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

8.  The design and analysis of randomized trials with recurrent events.

Authors:  R J Cook
Journal:  Stat Med       Date:  1995-10-15       Impact factor: 2.373

9.  Sample-size formula for the proportional-hazards regression model.

Authors:  D A Schoenfeld
Journal:  Biometrics       Date:  1983-06       Impact factor: 2.571

10.  Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Authors:  H J Fuchs; D S Borowitz; D H Christiansen; E M Morris; M L Nash; B W Ramsey; B J Rosenstein; A L Smith; M E Wohl
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

View more
  3 in total

1.  A model-informed rank test for right-censored data with intermediate states.

Authors:  Ritesh Ramchandani; Dianne M Finkelstein; David A Schoenfeld
Journal:  Stat Med       Date:  2015-01-13       Impact factor: 2.373

2.  Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.

Authors:  Ming-Hui Chen; Joseph G Ibrahim; Donglin Zeng; Kuolung Hu; Catherine Jia
Journal:  Biometrics       Date:  2014-07-16       Impact factor: 2.571

3.  Insights on the robust variance estimator under recurrent-events model.

Authors:  Hussein R Al-Khalidi; Yili Hong; Thomas R Fleming; Terry M Therneau
Journal:  Biometrics       Date:  2011-03-18       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.